GENERAL-PRACTITIONERS FOR RATIONAL USE OF DRUGS - EXAMPLES FROM SWEDEN

被引:13
作者
TOMSON, Y
WESSLING, A
TOMSON, G
机构
[1] KAROLINSKA INST,HUDDINGE HOSP,DEPT CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN
[2] NATL CORP SWEDISH PHARMACIES,STOCKHOLM,SWEDEN
[3] KAROLINSKA INST,DEPT INT HLTH & SOCIAL MED,UNIT INT HLTH CARE RES,STOCKHOLM,SWEDEN
关键词
GENERAL PRACTICE; DRUG PRESCRIPTION; CLINICAL PHARMACOLOGY; DRUG INFORMATION; HEALTH ECONOMY; ESSENTIAL DRUG LIST;
D O I
10.1007/BF02570500
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the south west region of Stockholm a group of 125 general practitioners (GPs) at 27 health centres asked about the extent to which the drug formulary of the University Hospital was useful in their practices. To answer this question, the GPs asked their local pharmacies for prescribing data. When presented this started a process towards rational prescribing from within the group of GPs, including repeated prescribing surveys, starting with health centres as the unit of analysis and proceeding to individual prescribing analyses on request by the GPs. As the prescribing data revealed major differences between health centres, the GPs arranged two workshops on drug use in primary health care. They developed a list of 167 recommended drugs based on drug statistics and morbidity in general practice. Signs of increased cost cautiousness could be shown. There was a clear trend towards both smaller volumes and cost per prescription item for the health centres in the study area. Compared to the national prescribing pattern, prescribing practice in the study area represented a 20 per cent lower drug cost. Although the GPs decided on a drug list separate from that of the hospital, collaboration between the Drug and Therapeutic Committee at the hospital and the GPs in creased as a result of their increased engagement in drug management, thereby also bridging the gap between primary health care and clinical pharmacology.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 23 条
[1]  
AGENAS I, 1985, LAKARTIDNINGEN, V82, P510
[2]   SCIENTIFIC VERSUS COMMERCIAL SOURCES OF INFLUENCE ON THE PRESCRIBING BEHAVIOR OF PHYSICIANS [J].
AVORN, J ;
CHEN, M ;
HARTLEY, R .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (01) :4-8
[3]  
BEERMANN B, 1985, LAKARTIDNINGEN, V82, P508
[4]  
BLOCK I, 1986, LAKARTIDNINGEN, V83, P666
[5]  
CROOKS J, 1978, ADV PHARMACOL THER, V6, P189
[6]   RANDOMIZATION BY GROUP IN STUDYING THE EFFECT OF DRUG INFORMATION IN PRIMARY CARE [J].
DIWAN, VK ;
ERIKSSON, B ;
STERKY, G ;
TOMSON, G .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1992, 21 (01) :124-130
[7]   CLINICAL-PHARMACOLOGY AND PRIMARY HEALTH-CARE IN EUROPE - A GAP TO BRIDGE [J].
DUKES, G ;
LUNDE, PKM ;
MELANDER, A ;
ORME, M ;
SJOQVIST, F ;
TOGNONI, G ;
WESSELING, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (04) :315-318
[8]  
GRANT GB, 1985, LANCET, V1, P1030
[9]   EFFECT OF CLINICAL GUIDELINES ON MEDICAL-PRACTICE - A SYSTEMATIC REVIEW OF RIGOROUS EVALUATIONS [J].
GRIMSHAW, JM ;
RUSSELL, IT .
LANCET, 1993, 342 (8883) :1317-1322
[10]  
Hammarstrom B, 1988, World Health Forum, V9, P514